Compare SPT & NGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SPT | NGEN |
|---|---|---|
| Founded | 2010 | 2017 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | |
| Sector | Technology | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 327.6M | 317.6M |
| IPO Year | 2019 | N/A |
| Metric | SPT | NGEN |
|---|---|---|
| Price | $5.54 | $3.73 |
| Analyst Decision | Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $12.38 | N/A |
| AVG Volume (30 Days) | ★ 1.7M | 101.3K |
| Earning Date | 05-07-2026 | 04-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 32.11 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $457,547,000.00 | N/A |
| Revenue This Year | $9.03 | N/A |
| Revenue Next Year | $8.83 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 12.72 | N/A |
| 52 Week Low | $5.39 | $3.51 |
| 52 Week High | $24.74 | $5.93 |
| Indicator | SPT | NGEN |
|---|---|---|
| Relative Strength Index (RSI) | 34.76 | 38.60 |
| Support Level | N/A | $3.69 |
| Resistance Level | $7.39 | $4.44 |
| Average True Range (ATR) | 0.31 | 0.22 |
| MACD | 0.06 | -0.01 |
| Stochastic Oscillator | 15.75 | 33.90 |
Sprout Social Inc develops a cloud software that brings together social messaging, data and workflows in a unified system of record, intelligence, and action. It has a centralized, secure and powerful platform that can scale horizontally across an organization to drive maximum business value. The firm generates majority revenue from software subscriptions. Geographically, the company operates in Americas, EMEA, and Asia Pacific, of which it derives maximum revenue from Americas.
NervGen Pharma Corp is a clinical-stage biotech company. The company's principal business activity is the discovery, development, and commercialization of pharmaceutical treatments that enable the nervous system to repair itself following damage, whether due to injury or disease. The company's initial target indication is spinal cord injury. The company's pipeline products include NVG-291 and NVG-300.